Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Annals of Hematology|March 7, 2024
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy populationEmily L Gill, Christian M Gill, Colleen McEvoyThe Journal of Antimicrobial Chemotherapy|October 15, 2023
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and EnterobacteralesAliaa Fouad, David P Nicolau, Christian M GillThe Journal of Antimicrobial Chemotherapy|June 26, 2023
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamasesYasmeen Abouelhassan, Christian M Gill, David P NicolauThe Journal of Antimicrobial Chemotherapy|January 13, 2024
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposuresVictor H Ruiz, Christian M Gill, David P NicolauThe Journal of Antimicrobial Chemotherapy|October 26, 2020
Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection modelChristian M Gill, Tomefa E Asempa, David P NicolauAntibiotics (Basel, Switzerland)|October 30, 2020
Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosaChristian M Gill, Tomefa E Asempa, David P NicolauEmerging Microbes & Infections|March 4, 2022
Carbapenemase-producing Pseudomonas aeruginosa -an emerging challengeFred C Tenover, David P Nicolau, Christian M GillASM Case Reports|November 17, 2025
Cefepime failure for the treatment of cefepime-susceptible, KPC-producing Escherichia coli emphysematous cystitisJordynne Morelan, Rong Hou, Robin Chamberland, et al.The Journal of Antimicrobial Chemotherapy|October 15, 2023
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosaSu Young Lee, Christian M Gill, David P Nicolau, et al.Antimicrobial Agents and Chemotherapy|May 20, 2020
Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are ImperativeChristian M Gill, Tomefa E Asempa, David P NicolauPageof 6